The New England Journal of Medicine22d
Sepsis and Septic Shock
ARISE: 1600 patients with septic shock at 51 sites in Australia and New Zealand ProCESS: 1341 patients with septic shock at 31 U.S. sites ProMISe: 1260 patients with septic shock at 56 U.K. sites ...
Nature3y
The key to treating sepsis and septic shock: matching treatment to causal pathophysiology
which will use refined inclusion/exclusion criteria and explore the benefits of earlier intervention, with separate trials for sepsis and septic shock. The ENCOURAGE trials will form the basis for ...
pulmonologyadvisor9d
Albumin in Septic Shock: Early Use With Kidney Impairment Tied to Worse Outcomes
Caution is urged with early albumin use in septic shock and kidney impairment, especially with hyperoncotic vs isooncotic albumin.
Too Old to Operate5d
Delayed Second Antibiotic Dose in Septic Shock Linked to Higher Mortality
The following is a summary of “Association of second antibiotic dose delays on mortality in patients with septic shock,” ...
Medscape1y
Revisiting the Role of Hydrocortisone, Fludrocortisone in Septic Shock
He contended that the COIITTS trial was underpowered and the two Annane RCTs that used fludrocortisone supply the evidence that shows corticosteroids reduce septic shock mortality. As discussed ...
Medscape3d
Use of Granulocyte Colony-stimulating Factor in Patients with Severe Sepsis or Septic Shock
Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...